← Leaderboards
Edward Vincent Faustino
Yale University
$4,510,418
Attributed
$5,796,542
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2017–25$2.5M$1.9M$1.3M$625K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,796,542 · 4
By mechanism
R01$5,306,630 · 3
R21$489,912 · 1
Top collaborators
- Philip C Spinella2 shared
- John Hwa1 shared
- Richard W Pierce1 shared
- Maor Sauler1 shared
- Xiting Yan1 shared
Most similar at Yale University
Same institution · by research overlap
- Margretta Seashore$51,578
- Albert J Sinusas$22,904,679
- Kim Germaine Smolderen$1,112,640
- Adam H. De Havenon$5,725,083
- Chi Liu$11,811,709
Others in their field
Other Emerging Leaders on “Adult”
- Beth Baseler · Leidos Biomedical Research, Inc.$127,607,354
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$93,592,175
- Susan M Landau · University Of California Berkeley$47,252,026
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$42,295,422
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
- Evan Z Macosko · Broad Institute, Inc.$32,116,761
Research focus
AdultChildChildhoodCritically Ill ChildrenHemorrhagePreventThrombosisObservational StudyInnovationProphylacticHourIncidenceCessation Of LifePharmaceutical PreparationsCathetersGenerationsBlood CoagulationAnticoagulantsDeep Vein ThrombosisCritical IllnessDoseBayesian AnalysisClinically RelevantEnoxaparin
Grant awards (9)
Interrupting pro-inflammatory pulmonary-vascular cell interactions to reduce pulmonary capillary leak in critically ill children with bronchiolitis$958,850
R01 · FY2025 · HL
Age-dependent heterogeneity in the efficacy of prophylaxis with enoxaparin against catheter-associated thrombosis in critically ill children$702,712
R01 · FY2025 · HD · contact PI
Platelet dysfunction in pediatric multiple organ dysfunction syndrome: Role of unfolded protein response$644,061
R01 · FY2025 · HD · contact PI
Age-dependent heterogeneity in the efficacy of prophylaxis with enoxaparin against catheter-associated thrombosis in critically ill children$689,349
R01 · FY2024 · HD · contact PI
Age-dependent heterogeneity in the efficacy of prophylaxis with enoxaparin against catheter-associated thrombosis in critically ill children$692,553
R01 · FY2023 · HD · contact PI
Age-dependent heterogeneity in the efficacy of prophylaxis with enoxaparin against catheter-associated thrombosis in critically ill children$818,478
R01 · FY2022 · HD · contact PI
Age-dependent heterogeneity in the efficacy of prophylaxis with enoxaparin against catheter-associated thrombosis in critically ill children$800,627
R01 · FY2021 · HD · contact PI
Prevention of central venous catheter-associated thrombosis in critically ill children$198,356
R21 · FY2018 · HD · contact PI
Prevention of central venous catheter-associated thrombosis in critically ill children$291,556
R21 · FY2017 · HD · contact PI